MIRM
Mirum Pharmaceuticals Inc
NASDAQ: MIRM · HEALTHCARE · BIOTECHNOLOGY
$94.20
+0.21% today
Updated 2026-04-29
Market cap
$5.74B
P/E ratio
—
P/S ratio
11.02x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$40 – $109
Volume
0.8M
Mirum Pharmaceuticals Inc (MIRM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-373000.00 | $-39.36M | $-89.08M | $-132.76M | $-120.14M | $-70.94M | $10.32M | $55.83M |
| Capital expenditures | $7.50M | $281000.00 | $225000.00 | $19.02M | $278000.00 | $20.11M | $993000.00 | $954000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $51000.00 | $6.07M | $12.55M | $23.09M | $27.01M | $35.02M | $48.44M | $71.42M |
| Free cash flow | $-7.87M | $-39.64M | $-89.30M | $-151.78M | $-120.41M | $-91.05M | $9.33M | $54.87M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | — | — | $0.00 | $5.55M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | — | $130.09M | $-10.74M | $-3.35M | — | — | — |